[ad_1] October 9, 2018 FDA has granted Gardasil 9 priority review status for the application The Food and Drug Administration (FDA) has extended the approval of Gardasil 9 (human papillomavirus vaccine 9 …
Read More »La FDA étend Gardasil pour couvrir les adultes jusqu'à 45 ans
[ad_1] 8 octobre 2018 – La FDA a approuvé une application supplémentaire pour Gardasil 9, le vaccin contre le VPH de Merck destiné aux hommes et aux femmes âgés de 27 à …
Read More »FDA approves increased use of Gardasil 9
[ad_1] The Food and Drug Administration (FDA) has announced the approval of an additional application for the 9-valent vaccine against recombinant human papillomavirus (HPV), expanding the approved use of the vaccine to …
Read More »FDA approves extensive use of Gardasil 9 to include individuals aged 27 to 45
[ad_1] The US Food and Drug Administration today approved an additional application for the 9-valent human recombinant papillomavirus (HPV) vaccine, expanding the approved use of the vaccine to women and men aged …
Read More »